We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

pAdVAntage™ Vector

Enhances Protein Expression in Mammalian Cells When Cotransfected

  • Increases translation initiation in cells transiently transfected with protein expression constructs
  • Can be used in a variety of cell lines

Size

Catalog number selected: E1711

$ 147.00
Your price:
Add to Cart
This product is discontinued
Add to Helix
pAdVAntage™ Vector
20μg
$ 147.00
Your price: Log in

Co-transfection of mammalian cells with the pAdVAntage™ Vector enhances transient protein expression in a variety of cell types by increasing translation initiation. Luciferase constructs co-transfected with the pAdVAntage™ Vector showed at least a tenfold increase in luciferase expression in 293 and HeLa cell lines over transfections performed with the construct DNA alone.

Transfection of mammalian cells with an expression vector often results in suboptimal expression of the protein of interest. Double-stranded RNA (dsRNA) generated during transfection is thought to activate the dsRNA-activated inhibitor (DAI), one of several enzymes involved in the host cell's antiviral defense system. DAI phosphorylates the translation initiation factor eIF-2, halting translation and therefore protein production.

However, DAI translation inhibition can be overcome with the adenoviral Virus Associated I RNA (VAI RNA) produced by RNA polymerase III following co-transfection with the pAdVAntage™ Vector. The VAI RNA binds to DAI, preventing its activation, thereby allowing translation and protein expression.

References

  1. Farrell, P.J. et al. (1977) Cell 11, 187–200.
  2. Groskreutz, D. and Schenborn, E. (1994) Promega Notes 48, 8–12.
  3. Kitajewski, J. et al. (1986) Cell 45, 195–200.
  4. O'Malley, R.P. et al. (1986) Cell 44, 391–400.

 

Sequence Information

pAdVAntage™ Vector GenBank® Accession Number U47294 and vector sequence text file.

Specifications

What's in the box?

Item Part # Size

pAdVAntage™ Vector

E171A 1 × 20μg

SDS

Choose language:

Download SDSPDF (41 KB) – English (United States)

Certificate of Analysis

See all certificates for E1711

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

BB

Let's find the product that meets your needs.

Talk to a Scientist

Maria

Maria

Spain